Agappe Diagnostics / Point of care
Pathfast
Cardiac Biomarker Analyzer with CLEIA Technology
Machines & equipment
Pathfast is listed in Agappe’s point of care collection as a cardiac Biomarker Analyzer with CLEIA Technology.
01 / A CLOSER LOOK
Features that
define the product.
| FEATURES | DESCRIPTION |
|---|---|
| Instrument type | Bench-top Cardiac Biomarker Analyzer |
| Throughput | Up to 6 samples or assays per run |
| Measuring time | <17 minutes for up to six simultaneous samples |
| Sampling material | Whole blood, plasma |
| Measuring principle | Chemiluminescence enzyme immunoassay technology (CLEIA) combined with proprietary Magtration™ technology |
| Reaction temperature | 37.5º C |
| Sample volume | 100μL |
| Wavelength | 300 – 650 nm |
| Data storage | Patient data: 1000 |
| QC data | 1800 |
| CAL data | 300 |
| Data transfer | ASTM standard |
| Dimensions | 13.5 in. W x 22.4 in. D x 18.7 in. H |
| Weight | 62 lbs |
| Electrical requirements | : 100 – 240 Vac |
| Monitor/keyboard | LCD Touchscreen |
| Printer | Integrated |
| PC | Integrated |
| Interface | RS-232C |
| Calibration | Factory calibration, 2-point calibration every 4 weeks |
| 24-h operation (standby) | 24-h operation (standby) |
02 / HOW IT WORKS
The technology.
The PATHFAST analyzer utilizes a combination of chemiluminescence enzyme immunoassay (CLEIA) technology and proprietary Magtration technology to provide highly accurate, lab-quality results from whole blood samples. This technology allows for the detection of small sample volumes with high precision and sensitivity.
03 / KEEP THE DETAILS
